摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

p-(2-phenylisopropyl)phenol | 74475-04-0

中文名称
——
中文别名
——
英文名称
p-(2-phenylisopropyl)phenol
英文别名
4-(1-Phenylpropan-2-yl)phenol
p-(2-phenylisopropyl)phenol化学式
CAS
74475-04-0
化学式
C15H16O
mdl
——
分子量
212.291
InChiKey
ZQQDMQVOOQZOOA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为产物:
    描述:
    2-diazo-1-naphthol-5-sulfonyl chloride盐酸 作用下, 以 吡啶 、 (2S)-N-methyl-1-phenylpropan-2-amine hydrate 为溶剂, 生成 p-(2-phenylisopropyl)phenol
    参考文献:
    名称:
    Method of purifying
    摘要:
    一种通过溶解在有机溶剂中,通过添加特定的非溶剂重新沉淀,并从特定的溶剂中重新结晶再沉淀的方法,纯化粗2,4-双(6-重氮基-5,6-二氢-5-氧代-1-萘磺酸酯基)苯酮。
    公开号:
    US04024122A1
点击查看最新优质反应信息

文献信息

  • [EN] MANUFACTURE OF EPOXYETHYL ETHERS OR GLYCIDYL ETHERS<br/>[FR] FABRICATION D'ÉTHERS D'ÉPOXYÉTHYLE OU D'ÉTHERS DE GLYCIDYLE
    申请人:MOMENTIVE SPECIALTY CHEMICALS RES S A
    公开号:WO2011095293A1
    公开(公告)日:2011-08-11
    Processes are provided for the formation of an epoxyethyl ether or a glycidyl ether, hi one embodiment, a process is provided for the manufacture of an epoxyethyl ether or glycidyl ether including reacting a vinyl ether or an allyl ether with an oxidant in the presence of a water-soluble manganese complex in an aqueous reaction medium, wherein the water-soluble manganese complex comprises an oxidation catalyst, characterized in that the water-soluble manganese complex is a mononuclear complex of the general formula (I): [LMnX3]Y (I), or a binuclear complex of the general formula (II): [LMn(μ-X)3MnL](Y)n (II), wherein Mn is a manganese; L or each L independently is a polydentate ligand, each X independently is a coordinating species and each μ-X independently is a bridging coordinating species, Y is a non-coordinating counter ion, and wherein the epoxidation is carried out at a pH in the range of from 1.0 to 6.0. The invention also relates to epoxyethyl ethers.
    提供了一种形成环氧乙基醚或环氧基醚的工艺。在一个实施例中,提供了一种用于制造环氧乙基醚或环氧基醚的工艺,包括在水溶性锰配合物存在的水相反应介质中,将乙烯醚或烯丙基醚与氧化剂反应,其中水溶性锰配合物包括氧化催化剂,其特征在于水溶性锰配合物是通式(I)的单核配合物:[LMnX3]Y (I),或通式(II)的双核配合物:[LMn(μ-X)3MnL](Y)n (II),其中Mn是锰;L或每个L独立地是多齿配体,每个X独立地是一个配位物种,每个μ-X独立地是一个桥联配位物种,Y是一个非配位的反离子,环氧化在pH值为1.0至6.0的范围内进行。该发明还涉及环氧乙基醚。
  • THERMOCHROMIC PIGMENT COMPOSITIONS
    申请人:SOCIETE BIC
    公开号:US20200207699A1
    公开(公告)日:2020-07-02
    A thermochromic pigment composition including compounds of formula (I): in which: X represents CHR 2 , O, OCO or CH═CH; Y represents O, COO, or OCOO; R 1 represents H or (CH 2 ) p CH 3 ; R 2 represents phenyl or H; m=12-18; n=0-14; p=12-18; and on the condition that, if n=0, X represents CHR 2 or CH═CH. The thermochromic pigment compositions having compounds of formula (I), include thermochromic pigment microcapsules. The thermochromic pigment capsules are useable for thermochromic pigment compositions in ink which may be used writing instruments.
    一种热变色颜料组合物,包括以下化合物(I)的化合物: 其中:X代表CHR2、O、OCO或CH═CH;Y代表O、COO或OCOO;R1代表H或(CH2)pCH3;R2代表苯基或H;m=12-18;n=0-14;p=12-18;并且在条件下,如果n=0,X代表CHR2或CH═CH。含有化合物(I)的热变色颜料组合物包括热变色颜料微胶囊。这些热变色颜料胶囊可用于墨水中的热变色颜料组合物,可用于书写工具。
  • [EN] DIESTER OF BISPHENOL FLUORENE COMPOUNDS AND THERMOCHROMIC PIGMENT COMPOSITIONS COMPRISING THE SAME<br/>[FR] DIESTER DE COMPOSÉS DE BISPHÉNOL FLUORÈNE ET COMPOSITIONS DE PIGMENTS THERMOCHROMIQUES COMPRENANT CELUI-CI
    申请人:SOCIÉTÉ BIC
    公开号:WO2020064537A1
    公开(公告)日:2020-04-02
    The present invention relates to the use of a compound represented by formula (I), wherein R1 and R2, identical or different, represent a C2-C30 alkyl group, a C2-C30 alkenyl group, a C2-C30 alkynyl group, or a C2-C30 alkoxy group, said alkyl, alkenyl, alkynyl, or alkoxy groups being optionally substituted with at least one hydroxy, halogen, amino, C1-C8 alkyl, or C1-C8 alkoxy group, as a temperature change regulating agent in a thermochromic ink composition. The present invention also relates to thermochromic pigment microcapsules comprising a compound of formula (I) according to the invention, to ink compositions comprising such thermochromic pigment microcapsules, and to writing instruments comprising such ink compositions. Finally, the invention also relates to a specific compound of formula (II) as such.
    本发明涉及使用式(I)所表示的化合物作为温度变化调节剂,其中R1和R2,相同或不同,表示C2-C30烷基,C2-C30烯基,C2-C30炔基或C2-C30烷氧基,所述烷基,烯基,炔基或烷氧基可以选择地被替换为至少一个羟基,卤素,氨基,C1-C8烷基或C1-C8烷氧基。本发明还涉及包含本发明中式(I)的化合物的热致变色颜料微囊,含有这样的热致变色颜料微囊的油墨组合物,以及含有这样的油墨组合物的书写工具。最后,本发明还涉及式(II)的特定化合物。
  • [EN] METHOD FOR PRODUCING POLYCARBONATE OLIGOMERS<br/>[FR] PROCÉDÉ DE PRODUCTION D'OLIGOMÈRES DE POLYCARBONATE
    申请人:SHELL OIL CO
    公开号:WO2017112625A1
    公开(公告)日:2017-06-29
    A process for producing an oligomer comprising contacting a dialkyl carbonate and a dihydroxy compound in a reaction zone in the presence of an oligomerization catalyst under oligomerization conditions to form the oligomer wherein the molar ratio of dihydroxy compound to dialkyl carbonate in the reaction zone is at least 2:1.
    一种生产寡聚体的方法,包括在寡聚化催化剂的存在下,在反应区内将二元酸酯和二羟基化合物接触,以在寡聚化条件下形成寡聚体,其中反应区内二羟基化合物与二元酸酯的摩尔比至少为2:1。
  • S1P receptor modulating compounds and use thereof
    申请人:Burli Roland
    公开号:US20080027036A1
    公开(公告)日:2008-01-31
    The present invention relates to compounds of the general formula (I) that have activity as S1P receptor modulating agents and the use of such compounds to treat diseases associated with inappropriate S1P receptor activity. The compounds may be used as immunomodulators, e.g., for treating or preventing diseases such as autoimmune and related immune disorders including systemic lupus erythematosus, inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, type I diabetes, uveitis, psoriasis, myasthenia gravis, rheumatoid arthritis, non-glomerular nephrosis, hepatitis, Behçet's disease, glomerulonephritis, chronic thrombocytopenic purpura, hemolytic anemia, hepatitis and Wegner's granuloma; and for treating other conditions.
    本发明涉及一般式(I)的化合物,其具有作为S1P受体调节剂的活性,以及使用这种化合物来治疗与不适当的S1P受体活性相关的疾病。这些化合物可以用作免疫调节剂,例如,用于治疗或预防自身免疫和相关免疫紊乱疾病,包括系统性红斑狼疮、炎症性肠病,如克隆病和溃疡性结肠炎、1型糖尿病、葡萄膜炎、牛皮癣、重症肌无力、类风湿性关节炎、非肾小球性肾病、肝炎、Behçet病、肾小球肾炎、慢性血小板减少性紫癜、溶血性贫血、肝炎和Wegner肉芽肿;以及用于治疗其他疾病。
查看更多

同类化合物

(E,Z)-他莫昔芬N-β-D-葡糖醛酸 (E/Z)-他莫昔芬-d5 (4S,5R)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4R,4''R,5S,5''S)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (1R,2R)-2-(二苯基膦基)-1,2-二苯基乙胺 鼓槌石斛素 高黄绿酸 顺式白藜芦醇三甲醚 顺式白藜芦醇 顺式己烯雌酚 顺式-桑皮苷A 顺式-曲札芪苷 顺式-二苯乙烯 顺式-beta-羟基他莫昔芬 顺式-a-羟基他莫昔芬 顺式-3,4',5-三甲氧基-3'-羟基二苯乙烯 顺式-1,2-二苯基环丁烷 顺-均二苯乙烯硼酸二乙醇胺酯 顺-4-硝基二苯乙烯 顺-1-异丙基-2,3-二苯基氮丙啶 阿非昔芬 阿里可拉唑 阿那曲唑二聚体 阿托伐他汀环氧四氢呋喃 阿托伐他汀环氧乙烷杂质 阿托伐他汀环(氟苯基)钠盐杂质 阿托伐他汀环(氟苯基)烯丙基酯 阿托伐他汀杂质D 阿托伐他汀杂质94 阿托伐他汀内酰胺钠盐杂质 阿托伐他汀中间体M4 阿奈库碘铵 银松素 铒(III) 离子载体 I 钾钠2,2'-[(E)-1,2-乙烯二基]二[5-({4-苯胺基-6-[(2-羟基乙基)氨基]-1,3,5-三嗪-2-基}氨基)苯磺酸酯](1:1:1) 钠{4-[氧代(苯基)乙酰基]苯基}甲烷磺酸酯 钠;[2-甲氧基-5-[2-(3,4,5-三甲氧基苯基)乙基]苯基]硫酸盐 钠4-氨基二苯乙烯-2-磺酸酯 钠3-(4-甲氧基苯基)-2-苯基丙烯酸酯 重氮基乙酸胆酯酯 醋酸(R)-(+)-2-羟基-1,2,2-三苯乙酯 酸性绿16 邻氯苯基苄基酮 那碎因盐酸盐 那碎因[鹼] 达格列净杂质54 辛那马维林 赤藓型-1,2-联苯-2-(丙胺)乙醇 赤松素 败脂酸,丁基丙-2-烯酸酯,甲基2-甲基丙-2-烯酸酯,2-甲基丙-2-烯酸